SPOTLIGHT: Phase 3 study of Zolbetuximab+mFOLFOX6 versus placebo+mFOLFOX6 in first-line claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)

Lordick, F.; Shitara, K.; Al-Batran, S. -E; Bang, Y. -J; Catenacci, D.; Enzinger, P.; Ilson, D.; Kim, S.; Shah, M. A.; Van Cutsem, E.; Xu, R. -H; Arozullah, A.; Park, J. W.; Ajani, J.

서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

S-Space

Publications

Detailed Information

SPOTLIGHT: Phase 3 study of Zolbetuximab+mFOLFOX6 versus placebo+mFOLFOX6 in first-line claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)

Cited 0 time in Web of Science Cited 0 time in Scopus

Export

Authors: Lordick, F.; Shitara, K.; Al-Batran, S. -E; Bang, Y. -J; Catenacci, D.; Enzinger, P.; Ilson, D.; Kim, S.; Shah, M. A.; Van Cutsem, E.; Xu, R. -H; Arozullah, A.; Park, J. W.; Ajani, J.